Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Patients typically start with an initial dose of 0.25 milligrams (mg) per week, which helps minimize potential side effects as your body adapts to the medication
North Carolina eliminated GLP-1 coverage beginning October 2025 due to a budget stalemate in the legislature, but coverage was reinstated in December 2025, bringing the total number of states covering GLP-1s for obesity to 13 as of January 2026
What was the early development failure of cagrilintide, and how was it overcome
They are not a recommendation, and no administration protocol is supplied with this product
Lilly warns that products claiming to be retatrutide outside its trials may contain unknown ingredients, contaminants, too much or too little active material, or a different substance entirely
